Exosomes control various biological processes, and they have showed potential in treating diseases including cardiovascular, immune, and neuronal diseases [39]. The horizontal transfer of biomolecules by exosomes was first demonstrated in 2007, whereby exosomal mRNA can be translated upon entering receiving cells [40]. Following this report, studies have demonstrated that exosomes carry lipids, proteins, microRNAs, lncRNAs, and circRNAs, which are involved in regulation of inflammatory response, cell proliferation, migration, angiogenesis, and ECM remodeling [41]. Importantly, these events are essential for successful wound healing, and maladaptive repair events can lead to chronic wound development.
The aim of the present study was to examine whether the HA stimulation of iMSCs can produce EVs that have enhanced function in the recovery of skin burn injury. HA-iMSC-EVs had proteins associated with the maintenance of skin integrity (ECM production and organization, TGF-β signaling, and PI3-AKT signaling etc.). Under H2O2-induced oxidative stress, the migration and viability of HDFs were increased by HA-iMSC-EVs compared with those treated with iMSC-EVs. The elevated level of IL-6 expression by H2O2 was reduced only by HA-iMSC-EVs. Additionally, the mRNA expression of key growth factors was increased only by HA-iMSC-EVs. Also, the decrease of elastin and collagen protein expression by oxidative stress was reversed by both iMSC-EVs and HA-iMSC-EVs, but its effect was more significant in HA-iMSC-EVs. In burn-injured mice, accelerated wound closure was observed only in animals that received HA-iMSC-EVs. The expression of collagen in skin tissue was enhanced only by HA-iMSC-EVs. Both iMSC-EVs and HA-iMSC-EVs stimulated elastin production, with the latter more significant. The recovery of capillary density as well as reduction of α-SMA expression in dermal layer was observed only in animals that received HA-iMSC-EVs. Together, these results suggest that HA treatment of iMSCs produce EVs having enhanced potential the recovery of skin tissue after burn injury by stimulating skin cell proliferation, growth factor production, vessel formation, and ECM production in the lesion.
Skin is the largest organ of the body and plays multiple roles including sensation, body heat regulation, protection, and host defense [42]. Skin is prone to various injuries including trauma, surgery, chronic disease, and burns. In healthy individuals, injured skin recovers through the four stages of wound healing: hemostasis, inflammation, proliferation, and remodeling [43]. On the other hand, some chronic wounds in diabetes or ischemia can cause an impaired wound healing process characterized by hypoxia, oxygen radicals, matrix metalloproteases, granulation tissue formation, reduced angiogenesis and decreased collagen synthesis and organization [44]. Following an acute burn injury, a strong inflammatory response occurs, which is characterized by neutrophil and macrophage recruitment to the injury site [12]. The innate immune cells and injured tissue release a wide range of inflammatory cytokines and growth factors (e.g., IL-1, IL-6, TGF-β, EGF, VEGF). When the production and secretion of these cytokines become excessive, wound closure can be delayed or the injury can progress to chronic stage [45]. Previous studies showed that MSC-EVs can block inflammation of skin burn injury; Li et al. showed that exosomal miR-181c from human umbilical cord-derived MSCs inhibited inflammation by suppressing Toll-like receptor 4 (TLR4) signaling in skin burn injury model as well as those in LPS-stimulated macrophages [46]. More recently, Liu et al. conducted single cell sequencing analysis from the peri-wound skin of mice that had undergone full-thickness excision injury, and found that exosomes from human umbilical cord MSCs led to an increase of the proportion of M2 macrophages and neutrophils [47]. Since inflammatory events can affect the degree of wound closure and scar formation [48], it would be needed to elucidate whether HA-iMSC-EVs can also repress the inflammation by regulating macrophage polarization at the early phase after injury.
Growth factors play crucial role in the wound healing process by regulating immune cells, promoting migration and proliferation of dermal cells (e.g., epithelial cells and fibroblasts), collagen synthesis, and differentiation [49]. For example, it was demonstrated that EGF is crucial for improvement of re-epithelialization [50], and that IGF-1 accelerates wound healing by promoting angiogenesis [51]. Also, HGF was shown to augment neovascularization, re-epithelialization of skin wounds, and granulation tissue formation [52]. However, due to the complexity of molecular pathways and wound chronicity, the local application of a single exogenous growth factor is insufficient to improve burn wounds [53]. Therefore, delivering a combination of growth factors using methods with high diffusion efficiency and bioavailability into the burn lesions is important for wound healing. Previous study showed that HA-iMSC-EVs enhance human umbilical vein endothelial cells (HUVEC) tube formation and angiogenesis [19]. Our study demonstrated that HA-iMSC-EVs increased the expression of various growth factors in skin fibroblasts. Thus, it is likely that HA-iMSC-EVs accelerated wound healing by improving re-epithelialization and neovascularization.
ECM deposition is the last phase during wound healing process, and its failure can lead to chronic wound or excessive scar formation. Collagen and elastin are the two most essential ECM proteins in skin [54], and collagen accounts for 50–90% of the dermal matrix. In line with our findings, Kim et al. reported that human umbilical cord-derived MSCs enhanced the cell migration as well as the synthesis of collagen and elastin in HDFs [55]. Furthermore, it has been shown that exosomes produced from human-induced pluripotent stem cell-derived MSCs (hiPSC-MSCs) promoted the expression of elastin, collagen I, and collagen III in HDFs [56]. In contrast, other studies demonstrated that MSC-derived exosomes inhibit the excessive production of ECM as well as fibroblast-to-myofibroblast transition, preventing scar formation. For example, it was shown that ADSC-derived exosomes reduced excessive scar formation by keeping fibroblasts from developing into myofibroblasts as well as controlling the ratios of TGF-β3/TGF-β1, collagen III/collagen I, and MMP3/TIMP1 [57]. We demonstrated that excessive expression of α-SMA was inhibited by HA-iMSC-EVs, which might have contributed to inhibiting excessive scar formation by the reducing the number of myofibroblasts, while increasing structural integrity (e.g., by collagen production) in dermis.
Elastin is responsible for tensile strength, providing structural integrity of skin. Mature, functional elastin is assembled from tropoelastin monomers through coacervation, cross-linking, and deposition [58]. However, the synthesis of new tropoelastin stops after the neonatal period [59], and insufficient elastic fiber network contributes to the reduced elasticity and resilience of the mature scar [60]. The restoration of an immediate and functional elastic fiber is, therefore, critical to regain complete skin function after injury, and it is needed to develop novel strategy to increase elastin to restore skin function. Our results demonstrated that the increase of elastin expression was higher in HA-iMSC-EVs compared with iMSC-EVs in the recovered skin. In the fibroblasts, elastin fibrils were observed only in the HA-iMSC-EVs. In support of this findings, bioinformatic analysis showed that HA-iMSC-EVs have proteomic profile that are related to ECM composition, and that enriched proteins in HA-iMSC-EVs were related to elastic fiber formation and collagen biosynthesis. One of the key protein families required for tissue remodeling after injury is matrix metalloproteinases (MMPs) [61]. It was shown that hADSC-Exos activated MAPK pathway, stimulating the production of MMP-3 and TIMP-1, which led to enhanced ECM remodeling [57]. Another study demonstrated that miRNA-21 in hADSC-Exos promoted MMP-9 levels, while decreased TIMP2 as well as TGF-β1, thus reducing the formation of wound scars [62]. Zhang et al. reported that hADSC-exos augmented MMP-1 expression and downregulated α-SMA expression, and that promoted collagen deposition, improving dermal thickening in full-thickness incision wound model [63]. Thus, other in-depth studies such as the role of HA-iMSC-EVs in regulating MMPs/TIMPs and myofibroblast activation are needed to further examine detailed mechanisms how ECM deposition was increased in dermal layer.
We observed that the increase of IL-6 expression in HDFs undergoing oxidative stress was inhibited only by HA-iMSC-EVs. Consistently, the dermal expression of α-SMA protein was reduced only by HA-iMSC-EVs. Previous study showed that IL-6 augments α-SMA expression and the differentiation of fibroblasts to myofibroblasts, which contract to bring the edges of the wound closer [64]. For this reason, therapeutic IL-6 blockade (tocilizumab) is currently used for treating fibrotic disease, such as systemic sclerosis [65]. Further detailed examinations should be followed by to determine the relationship between IL-6 and α-SMA expression during wound contraction induced by HA-iMSC-EVs.
Skin grafting is one of the standard measurements for severe (e.g., third-grade) or large burn injury [66]. Mostly, skin substitutes facilitate re-epithelialization underneath the skin substitute, some of which are composed of allogenic/xenogenic matrix with or without autologous or allogenic cells [67]. Skin substitutes can be also incorporated with collagen fiber, xenogenic ECM, growth factors, keratinocytes, fibroblasts etc., all of which contributes to wound repair and scar improvement [68]. Considering the pleiotropic function of stem cell exosomes (i.e., immune regulation, cell proliferation, ECM deposition), loading stem cell exosomes into scaffold or dermal graft may open a novel therapeutic strategy for burn injury and reducing scar formation [69].